---
figid: PMC7887571__ADVS-8-2002746-g006
figlink: pmc/articles/PMC7887571/figure/advs2285-fig-0006/
number: S1
caption: a) Schematic illustration of the HCJSP prodrug nanoparticle prepared via
  the host–guest interaction between HA‐CD and AD‐SS‐JQ1 and AD‐SS‐PPa. b) Proposed
  mechanisms of HCJSP‐based combinatory immunotherapy of pancreatic tumor by eliciting
  immunogenicity and overcoming adaptive immune resistance. HCJSP‐mediated PDT initiates
  ICD of the tumor cells, promotes DC maturation, and activates the CTLs for tumor
  regression. Meanwhile, BRD4i JQ1 can relieve PDT‐promoted glycolysis and immunosuppresive
  tumor microenvironment by impeding the transcription of c‐Myc and the downstream
  genes of the c‐Myc pathway, including HK‐2 and LDHA. Meanwhile, JQ1 can specifically
  downregulate IFN‐γ‐inducible PD‐L1 expression on the surface of the tumor cells
  for combating PDT‐inducible adaptive immune evasion.
pmcid: PMC7887571
papertitle: Regulating Glucose Metabolism with Prodrug Nanoparticles for Promoting
  Photoimmunotherapy of Pancreatic Cancer.
reftext: Fang Sun, et al. Adv Sci (Weinh). 2021 Feb;8(4):2002746.
pmc_ranked_result_index: '80634'
pathway_score: 0.9649075
filename: ADVS-8-2002746-g006.jpg
figtitle: a) Schematic illustration of the HCJSP prodrug nanoparticle prepared via
  the host–guest interaction between HA‐CD and AD‐SS‐JQ1 and AD‐SS‐PPa
year: '2021'
organisms:
- Homo sapiens
ndex: ''
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC7887571__ADVS-8-2002746-g006.html
  '@type': Dataset
  description: a) Schematic illustration of the HCJSP prodrug nanoparticle prepared
    via the host–guest interaction between HA‐CD and AD‐SS‐JQ1 and AD‐SS‐PPa. b) Proposed
    mechanisms of HCJSP‐based combinatory immunotherapy of pancreatic tumor by eliciting
    immunogenicity and overcoming adaptive immune resistance. HCJSP‐mediated PDT initiates
    ICD of the tumor cells, promotes DC maturation, and activates the CTLs for tumor
    regression. Meanwhile, BRD4i JQ1 can relieve PDT‐promoted glycolysis and immunosuppresive
    tumor microenvironment by impeding the transcription of c‐Myc and the downstream
    genes of the c‐Myc pathway, including HK‐2 and LDHA. Meanwhile, JQ1 can specifically
    downregulate IFN‐γ‐inducible PD‐L1 expression on the surface of the tumor cells
    for combating PDT‐inducible adaptive immune evasion.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - HK2
  - LDHA
  - BRD4
  - ADCY2
  - ADCY3
  - ADCY5
  - ADCY6
  - ADCY8
  - ADCY9
  - ADCY10
  - ADCY4
  - ADCY1
  - ADCY7
  - MYC
  - CD274
  - CALR
  - GSH
  - Oxygen
  - Glucose
  - Lactate
  - Pyruvate
  - Ac
  - Hypoxia - Glucose
  - ICD
genes:
- word: HK-2
  symbol: HK2
  source: hgnc_symbol
  hgnc_symbol: HK2
  entrez: '3099'
- word: LDHA
  symbol: LDHA
  source: hgnc_symbol
  hgnc_symbol: LDHA
  entrez: '3939'
- word: BRD4
  symbol: BRD4
  source: hgnc_symbol
  hgnc_symbol: BRD4
  entrez: '23476'
- word: Ac
  symbol: AC
  source: bioentities_symbol
  hgnc_symbol: ADCY2
  entrez: '108'
- word: Ac
  symbol: AC
  source: bioentities_symbol
  hgnc_symbol: ADCY3
  entrez: '109'
- word: Ac
  symbol: AC
  source: bioentities_symbol
  hgnc_symbol: ADCY5
  entrez: '111'
- word: Ac
  symbol: AC
  source: bioentities_symbol
  hgnc_symbol: ADCY6
  entrez: '112'
- word: Ac
  symbol: AC
  source: bioentities_symbol
  hgnc_symbol: ADCY8
  entrez: '114'
- word: Ac
  symbol: AC
  source: bioentities_symbol
  hgnc_symbol: ADCY9
  entrez: '115'
- word: Ac
  symbol: AC
  source: bioentities_symbol
  hgnc_symbol: ADCY10
  entrez: '55811'
- word: Ac
  symbol: AC
  source: bioentities_symbol
  hgnc_symbol: ADCY4
  entrez: '196883'
- word: Ac
  symbol: AC
  source: bioentities_symbol
  hgnc_symbol: ADCY1
  entrez: '107'
- word: Ac
  symbol: AC
  source: bioentities_symbol
  hgnc_symbol: ADCY7
  entrez: '113'
- word: C-Myc
  symbol: MYC
  source: hgnc_symbol
  hgnc_symbol: MYC
  entrez: '4609'
- word: с-Мус
  symbol: c-Myc
  source: hgnc_alias_symbol
  hgnc_symbol: MYC
  entrez: '4609'
- word: BRD4
  symbol: BRD4
  source: hgnc_symbol
  hgnc_symbol: BRD4
  entrez: '23476'
- word: Ac
  symbol: AC
  source: bioentities_symbol
  hgnc_symbol: ADCY2
  entrez: '108'
- word: Ac
  symbol: AC
  source: bioentities_symbol
  hgnc_symbol: ADCY3
  entrez: '109'
- word: Ac
  symbol: AC
  source: bioentities_symbol
  hgnc_symbol: ADCY5
  entrez: '111'
- word: Ac
  symbol: AC
  source: bioentities_symbol
  hgnc_symbol: ADCY6
  entrez: '112'
- word: Ac
  symbol: AC
  source: bioentities_symbol
  hgnc_symbol: ADCY8
  entrez: '114'
- word: Ac
  symbol: AC
  source: bioentities_symbol
  hgnc_symbol: ADCY9
  entrez: '115'
- word: Ac
  symbol: AC
  source: bioentities_symbol
  hgnc_symbol: ADCY10
  entrez: '55811'
- word: Ac
  symbol: AC
  source: bioentities_symbol
  hgnc_symbol: ADCY4
  entrez: '196883'
- word: Ac
  symbol: AC
  source: bioentities_symbol
  hgnc_symbol: ADCY1
  entrez: '107'
- word: Ac
  symbol: AC
  source: bioentities_symbol
  hgnc_symbol: ADCY7
  entrez: '113'
- word: PD-L1
  symbol: PD-L1
  source: hgnc_alias_symbol
  hgnc_symbol: CD274
  entrez: '29126'
- word: PD-L1
  symbol: PD-L1
  source: hgnc_alias_symbol
  hgnc_symbol: CD274
  entrez: '29126'
- word: CRT
  symbol: CRT
  source: hgnc_alias_symbol
  hgnc_symbol: CALR
  entrez: '811'
chemicals:
- word: GSH
  source: MESH
  identifier: D005978
- word: Oxygen
  source: MESH
  identifier: D010100
- word: Glucose
  source: MESH
  identifier: D005947
- word: Lactate
  source: MESH
  identifier: D019344
- word: Pyruvate
  source: MESH
  identifier: D011773
- word: Ac
  source: MESH
  identifier: D000186
diseases:
- word: Hypoxia - Glucose
  source: MESH
  identifier: D000860
- word: ICD
  source: OMIM
  identifier: '252500'
figid_alias: PMC7887571__S1
redirect_from: /figures/PMC7887571__S1
figtype: Scheme
---
